Press Releases by Category Health & Medicine
Cystinuria Market to Reach USD 2.5 Billion by 2034
Cystinuria is a rare inherited metabolic disorder characterized by defective renal transport of certain amino acids, particularly cystine, which leads to the formation of recurrent kidney stones. This autosomal recessive condition is caused by mutations in the SLC3A1 and SLC7A9 genes and affects approximately 1 in 7,000 to 1 in 10,000 individuals worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71685
Although not life-threatening when managed effectively, cystinuria poses a…
Microneedle Patches Market Revenue to Worth Over US$1,560.1 Million By 2033 | Da …
Overview of the Microneedle Patches Market
The Microneedle Patches Market is rapidly evolving as a pioneering solution for drug delivery, cosmetic applications, and disease management worldwide. Microneedle patches consist of an array of tiny, minimally invasive needles designed to penetrate the outer layer of skin painlessly, enabling efficient transdermal delivery of active ingredients or therapeutic agents. As needle phobia and demand for self-administered treatments surge, these patches offer a desirable alternative…
In Vitro Diagnostics (IVD) Market Projected to Hit USD 120 Billion by 2035, at a …
The In Vitro Diagnostics (IVD) Market Size is witnessing steady expansion, driven by the growing need for early disease detection, technological innovations in diagnostic tools, and the rising prevalence of chronic illnesses. According to industry experts, the market is benefiting from increasing adoption of personalized medicine and point-of-care testing, which are reshaping healthcare delivery worldwide. Hospitals, diagnostic laboratories, and home care settings are contributing significantly to the demand for advanced…
Physical Therapy Market Is Booming So Rapidly Growth by CAGR of 6.7% |Medtronic, …
The Global Physical Therapy Market is estimated to be valued at USD 28.07 Bn in 2025 and is expected to reach USD 44.20 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Physical Therapy Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry. This report delivers…
Cerebrotendinous Xanthomatosis (CTX) market is expected to reach USD 650 million …
Cerebrotendinous Xanthomatosis (CTX) is an ultra-rare autosomal recessive metabolic disorder caused by mutations in the CYP27A1 gene, leading to defective bile acid synthesis. The condition results in abnormal accumulation of cholestanol and cholesterol in various tissues, particularly the brain, eyes, and tendons. Clinical manifestations include progressive neurological decline, cataracts, tendon xanthomas, and chronic diarrhea. Without treatment, CTX can lead to severe disability and premature death.
Download Full PDF Sample Copy of…
Test Strip Market Overall Study Report 2025-2032 |Abbott Laboratories, Roche Dia …
The Global Test Strip Market is estimated to be valued at USD 14.25 Bn in 2025 and is expected to reach USD 18.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Test Strip Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry. This report delivers…
Angioedema Market to Reach USD 7.9 Billion by 2034
Angioedema is a condition characterized by sudden swelling in the deeper layers of the skin, often affecting the face, lips, tongue, throat, and extremities. It can be hereditary, acquired, drug-induced (commonly linked to ACE inhibitors), or idiopathic. Severe cases, particularly involving the airway, can be life-threatening.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71681
While antihistamines, corticosteroids, and epinephrine are often used in acute allergic angioedema, hereditary angioedema (HAE) has…
Assistive Technology Market Revolutionized by AI Innovation: Revenue to Reach US …
The global assistive technology market size was valued at USD 33.25 billion in 2024 and is poised to grow from USD 36.65 billion in 2025 to USD 88.00 billion by 2034, registering growth at 10.22% CAGR during the forecast period (2025-2034).
Artificial Intelligence (AI) and Internet of Things (IoT) technologies will remain at the forefront of transformative innovation among assistive technologies. Innovations such as smart prosthetics, AI-enhanced hearing aids, and IoT-integrated…
Idiopathic CD4 Lymphocytopenia (ICL) Market Detailed Industry Report Analysis 20 …
Introduction
Idiopathic CD4 lymphocytopenia (ICL) is a rare, acquired immune disorder characterized by persistently low CD4+ T-cell counts without evidence of HIV infection or other known immunodeficiencies. CD4 T-cells play a critical role in immune defense, and their deficiency leaves patients highly susceptible to opportunistic infections, malignancies, and autoimmune complications.
Since its first description in the 1990s, ICL has remained poorly understood, with its etiology still unclear. The rarity and diagnostic challenges…
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Market to Reach …
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID), also known as "bubble boy disease," is an ultra-rare genetic disorder caused by mutations in the ADA gene, leading to the absence of the adenosine deaminase enzyme. This results in toxic metabolite buildup and severe impairment of the immune system. Without treatment, infants with ADA-SCID typically do not survive beyond the first year of life.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71679
For…
Laser-Assisted Liposuction Market Size to Reach US$ 4,642.60 million by 2033 - E …
The Laser-Assisted Liposuction Market was valued at US$ 1,518.82 million in 2024 and is projected to reach US$ 4,642.60 million by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/laser-assisted-liposuction-market?sg
Mergers & Acquisitions 2025:
✅ Alma Lasers acquired a boutique U.S.-based body sculpting clinic chain in April 2025. This strategic move aims to scale up device deployment and…
Plastic Surgery Instruments Market Valued at USD 1,382.4 Million in 2025
Plastic Surgery Instruments Market is witnessing robust growth, supported by rising demand for both cosmetic and reconstructive surgeries. According to Fact.MR's latest report, the market is valued at USD 1,382.4 million in 2025, highlighting the critical role of specialized instruments in enhancing surgical precision and patient outcomes. The popularity of aesthetic enhancements, combined with the need for reconstructive solutions in trauma and medical cases, is fueling steady adoption worldwide.
For More…
Laband Syndrome Market Detailed Industry Report Analysis 2025-2034
Introduction
Laband syndrome, also known as Zimmermann-Laband syndrome (ZLS), is an ultra-rare genetic disorder characterized by gingival fibromatosis (severe gum overgrowth), distinctive craniofacial features, hypertrichosis, hepatosplenomegaly, and skeletal abnormalities such as hypoplastic nails, shortened distal phalanges, and joint hyperextensibility. The disorder has been associated with mutations in KCNH1 and ATP6V1B2 genes, which play roles in cellular signaling and ion channel regulation.
Because of its extreme rarity, Laband syndrome poses significant diagnostic and…
Animal Health Market to Surge with AI Innovation: Revenue Expected to Reach US$ …
The global animal health market size was valued at USD 63.3 billion in 2023 and is poised to grow from USD 67.92 billion in 2024 to USD 119.34 billion by 2032, growing at a CAGR of 7.3% in the forecast period (2025-2032). Additional market analysis projects the sector at USD 62.89 billion in 2024 with projected growth at a CAGR of 10.46% from 2025 to 2030.
AI integration will remain a…
Telepsychiatry Market Size to Reach US$ 102.62 billion by 2033 - Exclusive Repor …
The global telepsychiatry market was valued at US$ 24.36 billion in 2024 and is projected to reach US$ 102.62 billion by 2033, growing at a CAGR of 16.6% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/telepsychiatry-market?sg
Mergers & Acquisitions in Telepsychiatry (2025):
✅ Teladoc Health Acquires UpLift: In April 2025, Teladoc Health, a leader in virtual care, acquired UpLift, a tech-enabled provider of mental…
Wilson Disease Market is expected to reach USD 4.6 billion by 2034
Wilson Disease is a rare autosomal recessive genetic disorder caused by mutations in the ATP7B gene, leading to impaired copper metabolism. Excessive copper accumulation in the liver, brain, and other organs results in hepatic, neurological, and psychiatric manifestations. The estimated global prevalence is about 1 in 30,000 individuals, though diagnosis often remains delayed due to variable symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71677
Historically, treatment has relied on…
Spinal Surgery Products Market Expanding at 4.3% CAGR by 2035 | Key Players Cove …
The global spinal surgery products market continues to expand as demand for effective treatment options for spinal disorders increases. According to a recent analysis by Fact.MR, the market is valued at USD 12.4 billion in 2025, underscoring its vital role in the global healthcare industry. This growth is being driven by rising incidences of degenerative disc diseases, trauma cases, and spinal deformities, which are fueling the demand for advanced devices…
Von Hippel-Lindau (VHL) Disease Market to Reach USD 7.8 Billion by 2034
Von Hippel-Lindau (VHL) disease is a rare inherited disorder caused by mutations in the VHL tumor suppressor gene, leading to the development of benign and malignant tumors in multiple organs, including the kidneys, pancreas, adrenal glands, and central nervous system. The prevalence of VHL disease is estimated at 1 in 36,000 live births worldwide, and its multisystem involvement poses significant treatment challenges.
Download Full PDF Sample Copy of Market Report @…
Infantile Neuroaxonal Dystrophy (INAD) market is expected to reach USD 1.1 billi …
Infantile Neuroaxonal Dystrophy (INAD) is a devastating ultra-rare neurodegenerative disorder, typically presenting between 6 months and 3 years of age. It is most commonly associated with mutations in the PLA2G6 gene, leading to abnormal axonal swelling and progressive neurological decline. Children with INAD experience developmental delays, muscle weakness, vision loss, and cognitive impairment, with life expectancy often not extending beyond the first decade.
Download Full PDF Sample Copy of Market Report…
Lymphedema Market Size to Reach US$ 2,029.90 million by 2033 - Exclusive Report …
The lymphedema market was valued at US$ 989.85 million in 2024 and is projected to reach US$ 2,029.90 million by 2033, expanding at a CAGR of 8.8% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lymphedema-market?sg
Product Launches & Innovations
✅ Tactile Systems Technology: In May 2025, the company expanded the launch of its Nimbl device to include patients with lower extremity conditions, the largest…
Niemann-Pick Disease Type A (NPD-A) Market is expected to reach USD 3.5 billion …
Niemann-Pick Disease Type A (NPD-A) is a rare, inherited lysosomal storage disorder caused by mutations in the SMPD1 gene, resulting in deficient activity of acid sphingomyelinase (ASM). This leads to the accumulation of sphingomyelin in the liver, spleen, lungs, and brain, causing severe neurodegeneration. NPD-A typically manifests in infancy, and most affected children do not survive beyond early childhood, highlighting the urgent need for effective therapies.
Download Full PDF Sample Copy…
Beauty Devices Market Trends: Transforming Skincare with Smart Technology
The global beauty devices market is accelerating owing to the rising consumer beauty consciousness, especially among aging populations seeking noninvasive, at‐home anti‐aging, rejuvenation, and hair‐removal solutions. Additionally, social media, influencers, and celebrity endorsements have played a significant role in raising awareness and driving purchasing decisions. Technological innovation enhances personalization and effectiveness, boosting the adoption of beauty devices. Market players' growth initiatives are also expected to offer lucrative opportunities. For instance,…
Stargardt Disease Market is expected to reach USD 3.5 billion by 2034
Stargardt disease, the most common form of inherited juvenile macular degeneration, is caused by mutations in the ABCA4 gene. It typically manifests in late childhood or adolescence, leading to progressive central vision loss. With an estimated prevalence of 1 in 8,000 to 10,000 individuals worldwide, Stargardt disease is classified as a rare genetic disorder but represents a significant unmet need within ophthalmology.
Download Full PDF Sample Copy of Market Report @…
Mental Health Technology Market Size to Reach US$ 22.67 billion by 2033 - Exclus …
The mental health technology market was valued at US$ 7.97 billion in 2024 and is projected to reach US$ 22.67 billion by 2033, growing at a CAGR of 12.8% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/mental-health-technology-market?sg
Mergers & Acquisitions:
✅ Remedy Meds Acquires Thirty Madison
Telehealth startup Remedy Meds has acquired Thirty Madison in an all-stock deal valued at over $500 million. This strategic…
Pseudoxanthoma Elasticum (PXE) market is expected to reach USD 2.6 billion by 20 …
Pseudoxanthoma Elasticum (PXE) is a rare genetic disorder caused by mutations in the ABCC6 gene, leading to progressive mineralization of connective tissues. PXE primarily affects the skin, eyes, and cardiovascular system, resulting in skin laxity, vision loss due to choroidal neovascularization, and cardiovascular complications. The disease affects approximately 1 in 25,000 to 1 in 100,000 individuals worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71671
Historically, treatment has been limited…
Global Next-Generation Biomanufacturing Market is projected to reach the value o …
According to the report published by Virtue Market Research in Next-Generation Biomanufacturing Market was valued at USD 27.14 billion and is projected to reach a market size of USD 43.31 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 9.8%.
Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/next-generation-biomanufacturing-market/request-sample
Next-generation biomanufacturing is a big change in how new medicines and…
Propionic Acidemia (PA) market is expected to reach USD 2.3 billion by 2034
Propionic Acidemia (PA) is a rare autosomal recessive metabolic disorder caused by mutations in the PCCA or PCCB genes, leading to deficiency of the mitochondrial enzyme propionyl-CoA carboxylase. This results in toxic accumulation of organic acids, causing recurrent metabolic crises, developmental delays, cardiomyopathy, and neurological complications. PA affects approximately 1 in 100,000 to 150,000 live births globally, though incidence rates vary by geography.
Download Full PDF Sample Copy of Market Report…
Prader-Willi Syndrome (PWS) market is expected to reach USD 3.1 billion by 2034
Prader-Willi Syndrome (PWS) is a complex, rare genetic disorder caused by the loss of function of specific genes on chromosome 15. It is characterized by hypotonia, growth hormone deficiency, insatiable appetite (hyperphagia), developmental delays, and behavioral challenges. PWS affects approximately 1 in 10,000 to 30,000 people worldwide, making it one of the most common syndromic forms of obesity.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71667
For decades, treatment has…
Global Neurostimulatory Devices Market is projected to reach the value of USD 13 …
According to the report published by Virtue Market Research in Neurostimulatory Devices Market was valued at USD 7.28 billion and is projected to reach a market size of USD 13.18 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 12.6%.
Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/neurostimulatory-devices-market/request-sample
Neurostimulatory devices are tiny machines that help doctors treat brain and…
In Silico Drug Discovery Market Forecasted to Reach USD 13.76 Billion By 2034, a …
In Silico Drug Discovery Market: How Computational Power Is Rewiring Drug Research
Market overview
The In Silico Drug Discovery Market is shifting from experimental curiosity to everyday practice in pharmaceutical research, driven by advances in AI, machine learning, and high-performance computing. The global market was valued at USD 4.74 billion in 2024, is expected to reach USD 5.27 billion in 2025, and is projected to expand to USD 13.76 billion by 2034,…
Global Natural Lipid Market is projected to reach the value of USD 23.30 billion …
According to the report published by Virtue Market Research in Natural Lipid Market was valued at USD 13.87 billion and is projected to reach a market size of USD 23.30 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 10.93%.
Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/global-natural-lipids-market/request-sample
One major reason the natural lipid market continues to grow over…
Niemann-Pick Disease Type C (NPC) Market is expected to reach USD 2.8 billion by …
Niemann-Pick Disease Type C (NPC) is a rare, progressive, and life-threatening lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. The disease impairs cholesterol and lipid metabolism within cells, leading to severe neurological dysfunction, hepatosplenomegaly, and premature death. Affecting approximately 1 in 100,000 to 150,000 live births worldwide, NPC is often referred to as "childhood Alzheimer's" due to its devastating impact on cognition and motor skills.
Download Full…
Inhalation Capsules Market Set for Grow at a Rapid Pace During 2025-2032 says Co …
The Global Inhalation Capsules Market is estimated to be valued at USD 980.1 Mn in 2024 and is expected to reach USD 1,524.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Inhalation Capsules Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Pharmaceutical industry. This report delivers…
Neurofibromatosis Type 1 (NF1) Market to Reach USD 2.5 Billion by 2034
Neurofibromatosis Type 1 (NF1) is one of the most common genetic disorders among rare diseases, affecting approximately 1 in 3,000 individuals worldwide. It is caused by mutations in the NF1 gene, which encodes neurofibromin, a protein that helps regulate cell growth. Patients with NF1 develop benign tumors along nerves, skin abnormalities, and in some cases, malignant peripheral nerve sheath tumors (MPNSTs).
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71663
Historically,…
Imaging CRO Market Set for Considerable Market Growth Between 2025-2032 |Siemens …
The Global Imaging CRO Market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Imaging CRO Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Imaging industry. This report delivers…
Mucopolysaccharidosis II (Hunter Syndrome) market is expected to reach USD 2.8 b …
Mucopolysaccharidosis II (MPS II), commonly known as Hunter Syndrome, is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. The condition leads to abnormal accumulation of glycosaminoglycans (GAGs) in the body, resulting in developmental delays, organ dysfunction, and reduced life expectancy. Affecting approximately 1 in 100,000 to 1 in 170,000 male births, MPS II has historically been a severely debilitating and under-treated condition.
Download Full PDF…
Facial Fat Injections Market Set for Achieve Substantial Growth by 2025-2032 |Al …
The Global Facial Fat Injections Market is estimated to be valued at USD 1.44 Bn in 2025 and is expected to reach USD 2.34 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Facial Fat Injections Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry.…
Morquio Syndrome Market is expected to reach USD 3 billion by 2034
Morquio Syndrome, also known as Mucopolysaccharidosis Type IV (MPS IV), is a rare inherited lysosomal storage disorder characterized by the body's inability to break down glycosaminoglycans (GAGs). This leads to abnormal skeletal development, joint abnormalities, and impaired growth. Affecting approximately 1 in 200,000 to 1 in 300,000 live births, Morquio Syndrome is a debilitating condition with limited treatment options.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71659
Over the last…
Fibrotic Diseases Treatment Market is Projected to Reach USD 28.2 Billion, with …
Market Overview
The Fibrotic Diseases Treatment Market is witnessing significant expansion as healthcare providers globally focus on the development and adoption of innovative therapies for fibrotic conditions. Fibrosis is a pathological condition characterized by the excessive accumulation of scar tissue in various organs, including the lungs, liver, kidneys, heart, and skin. Left untreated, fibrosis can impair organ functionality, lead to chronic complications, and significantly reduce quality of life.
Fibrotic Diseases Treatment Market…
Point-of-care Ultrasound System Market Set for Considerable Market Growth Betwee …
The Global Point-of-care Ultrasound system Market is estimated to be valued at USD 5.71 billion in 2025 and is expected to reach USD 7.77 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.50% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Point-of-care Ultrasound System Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry.…
Removable Partial Denture Market Set for Experience Strong Growth by 2025-2032 | …
The Global Removable Partial Denture Market is estimated to be valued at USD 1.06 billion in 2025 and is expected to reach USD 1.43 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.33% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Removable Partial Denture Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry.…
Limb-Girdle Muscular Dystrophy (LGMD) Market to Hit USD 3.5 Billion by 2034
Limb-Girdle Muscular Dystrophy (LGMD) represents a heterogeneous group of inherited neuromuscular disorders characterized by progressive weakness in the shoulder and hip muscles. Affecting approximately 1 in 14,500 to 1 in 123,000 individuals globally, LGMD encompasses more than 30 genetic subtypes, each caused by mutations in different genes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71657
While historically underdiagnosed and poorly managed, advancements in genetic testing, biomarker research, and gene therapies…
Durable Medical Equipment Market to Reach USD 403 Billion by 2033 | Invacare, Su …
Valued at US$ 220 billion in 2023, the global durable medical equipment market is set to bring in revenue worth US$ 403 billion by the end of 2033. Worldwide sales of durable medical equipment (DME) are projected to rise at a noteworthy 6.2% CAGR over the next ten years (2023 to 2033).This growth is driven by an aging global population, rising prevalence of chronic diseases, increasing demand for home healthcare,…
Coronary Stents Market to Reach USD 38.5 Billion by 2033 | Abbott, Medtronic, Bo …
The global coronary stents market size is valued at US$ 13.7 Billion in 2023, and is projected to reach US$ 38.5 Billion by 2033, at a growing Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period from 2023 to 2033.This significant expansion is driven by the rising prevalence of cardiovascular diseases, an aging global population, and advancements in minimally invasive procedures like coronary stenting. The market is benefiting…
Hyperbaric Oxygen Therapy Devices Market to Reach USD 7.2 Billion by 2033 | Perr …
The global hyperbaric oxygen therapy devices market accounts for a valuation of US$ 3.5 billion in 2023 and is forecasted to climb to US$ 7.2 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for hyperbaric oxygen therapy devices is predicted to rise at a high-value 7.4% CAGR over the next ten years.according to a comprehensive report by Fact.MR. This significant growth is driven…
Hereditary Angioedema (HAE) market is expected to reach USD 4.2 billion by 2034
Hereditary Angioedema (HAE) is a rare, potentially life-threatening genetic disorder characterized by recurrent swelling episodes in the skin, gastrointestinal tract, and airways. Caused by C1 inhibitor deficiency or dysfunction, HAE affects an estimated 1 in 50,000 people worldwide. Though once underdiagnosed and undertreated, awareness and therapeutic innovation have dramatically changed the disease landscape in recent years.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71655
The HAE market has witnessed a…
Pulmonary Arterial Hypertension (PAH) Market to Reach USD 12.7 Billion by 2033 | …
The global pulmonary arterial hypertension market size was valued at US$ 5.4 Billion in 2023, and is projected to reach US$ 12.7 Billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2023 to 2033.This growth is driven by the increasing prevalence of cardiovascular diseases, rising geriatric populations, and advancements in PAH diagnosis and treatment solutions. The market is shaped by a…
Corneal Transplant Market Set Strategic Growth Amid Evolving Trends with Key Pla …
The Global Corneal Transplant Market is estimated to be valued at USD 469.9 million in 2025 and is expected to reach USD 711.3 million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Corneal Transplant Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Healthcare IT industry. This report delivers…
Ventricular Tachycardia Market to Reach USD 17 Billion by 2027, Growing at 5.26% …
Rising prevalence of cardiovascular diseases and advancements in treatment therapies fuel strong market expansion.
According to a new report, the Ventricular Tachycardia Market was valued at USD 12.5 billion in 2021 and is projected to reach USD 17 billion by 2027, growing at a CAGR of 5.26% during the forecast period. The market is driven by the increasing prevalence of cardiovascular diseases, advancements in catheter ablation procedures, and growing demand for…
Veress Needles Market 2025- 2032 Overview: Share, Size, Value, Trends, and Key P …
The Global Veress needles Market is estimated to be valued at USD 158.4 million in 2025 and is expected to reach USD 247.7 million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.
The latest market intelligence report published by Coherent Market Insights, titled "Global Veress Needles Market Size 2025: Growth Opportunities and Forecast," offers valuable insights into the Medical Devices industry. This report delivers…
Go To Page 11277 11276 11275 11274 11273 11272 11271 11270 11269 11268 11107 11106 11105 11104 11103 11102 11101 11100 11099 11098
